Company research / MGTX

MeiraGTx Holdings plc (MGTX)

CIK 0001735438 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, MeiraGTx Holdings plc reported revenue of $81.39M. Revenue grew 144.6% from the prior annual period.

Key ratios (year ended 2025-12-31)

-130.2%
Operating margin
-140.3%
Net margin
144.6%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-08-18

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.